IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - EPA:IPN - FR0010259150 - Common Stock
128.3 EUR
-2.3 (-1.76%)
Overall IPN gets a fundamental rating of 6 out of 10. We evaluated IPN against 54 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year IPN was profitable.
IPN had a positive operating cash flow in the past year.
IPN had positive earnings in each of the past 5 years.
Each year in the past 5 years IPN had a positive operating cash flow.
1.2 Ratios
IPN has a Return On Assets of 6.56%. This is comparable to the rest of the industry: IPN outperforms 57.41% of its industry peers.
IPN's Return On Equity of 10.59% is in line compared to the rest of the industry. IPN outperforms 55.56% of its industry peers.
The Return On Invested Capital of IPN (14.88%) is better than 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IPN is in line with the industry average of 14.51%.
The last Return On Invested Capital (14.88%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
The Profit Margin of IPN (11.91%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IPN has declined.
Looking at the Operating Margin, with a value of 26.01%, IPN is in the better half of the industry, outperforming 64.81% of the companies in the same industry.
IPN's Operating Margin has declined in the last couple of years.
IPN has a better Gross Margin (83.32%) than 90.74% of its industry peers.
In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
IPN has more shares outstanding than it did 1 year ago.
IPN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, IPN has an improved debt to assets ratio.
2.2 Solvency
IPN has an Altman-Z score of 4.65. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.65, IPN is doing good in the industry, outperforming 68.52% of the companies in the same industry.
IPN has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
IPN has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. IPN outperforms 88.89% of its industry peers.
IPN has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.20, IPN is in the better half of the industry, outperforming 75.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.65 |
ROIC/WACC1.89
WACC7.88%
2.3 Liquidity
IPN has a Current Ratio of 1.98. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
IPN has a Current ratio of 1.98. This is in the better half of the industry: IPN outperforms 74.07% of its industry peers.
IPN has a Quick Ratio of 1.80. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.80, IPN is in the better half of the industry, outperforming 79.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
IPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.45%.
IPN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.83% yearly.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.
Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 4.58% on average per year.
EPS Next Y6.71%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPS Next 5Y5.58%
Revenue Next Year8.23%
Revenue Next 2Y6.1%
Revenue Next 3Y6%
Revenue Next 5Y4.58%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.49, IPN is valued correctly.
Based on the Price/Earnings ratio, IPN is valued a bit cheaper than 74.07% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.51. IPN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 11.59, the valuation of IPN can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 72.22% of the companies listed in the same industry.
IPN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.49 | ||
| Fwd PE | 11.59 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IPN is valued cheaply inside the industry as 90.74% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IPN is valued a bit cheaper than 62.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.85 | ||
| EV/EBITDA | 6.19 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IPN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)1.42
EPS Next 2Y3.8%
EPS Next 3Y4.44%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.07%, IPN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.01, IPN has a dividend in line with its industry peers.
With a Dividend Yield of 1.07, IPN pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.07% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.9%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPA:IPN (11/18/2025, 7:00:00 PM)
128.3
-2.3 (-1.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.12%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.75B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts70
Price Target131.74 (2.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.07% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.27%
PT rev (3m)2.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.44%
EPS NY rev (3m)4.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.49 | ||
| Fwd PE | 11.59 | ||
| P/S | 2.86 | ||
| P/FCF | 20.85 | ||
| P/OCF | 11.98 | ||
| P/B | 2.54 | ||
| P/tB | 8.05 | ||
| EV/EBITDA | 6.19 |
EPS(TTM)10.27
EY8%
EPS(NY)11.07
Fwd EY8.63%
FCF(TTM)6.15
FCFY4.8%
OCF(TTM)10.71
OCFY8.34%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.86
PEG (5Y)1.42
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.65 |
F-Score7
WACC7.88%
ROIC/WACC1.89
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y6.71%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.23%
Revenue Next 2Y6.1%
Revenue Next 3Y6%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year32.82%
EBIT Next 3Y13.53%
EBIT Next 5Y7.88%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 6.71% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.